Dalfampridine is a medication used to improve walking in patients with multiple sclerosis. However, the drug can contain impurities that can affect its safety and efficacy. These impurities may include related compounds, degradation products, and residual solvents. It is important to identify and control these impurities to ensure the quality and safety of the medication.
